Literature DB >> 19649172

Effects of Patient Controlled Analgesia Hydromorphone during Acute Painful Episodes in Adolescents with Sickle Cell Disease: A Pilot Study.

Eufemia Jacob1, Marilyn Hockenberry, Brigitta U Mueller.   

Abstract

The use of hydromorphone is increasing but little is known about its effects during painful episodes in adolescents with sickle cell disease. This pilot study examined the intensity, location, and quality of pain and evaluated the amount of relief and side effects from PCA hydromorphone during acute painful episodes in five adolescents with sickle cell disease. Data suggest that hydromorphone may provide a better alternative than morphine, the most commonly prescribed opioid in patients with sickle cell disease. Hydromorphone may provide improved pain control and recovery from acute painful episodes in patients with sickle cell disease.

Entities:  

Year:  2008        PMID: 19649172      PMCID: PMC2718784     

Source DB:  PubMed          Journal:  J Pain Manag        ISSN: 1939-5914


  10 in total

1.  Assessment of sickle cell pain in children and young adults using the adolescent pediatric pain tool.

Authors:  Linda S Franck; Marsha Treadwell; Eufemia Jacob; Elliott Vichinsky
Journal:  J Pain Symptom Manage       Date:  2002-02       Impact factor: 3.612

2.  Management of vaso-occlusive pain in children with sickle cell disease.

Authors:  Eufemia Jacob; Christine Miaskowski; Marilyn Savedra; Judith E Beyer; Marsha Treadwell; Lori Styles
Journal:  J Pediatr Hematol Oncol       Date:  2003-04       Impact factor: 1.289

3.  Changes in intensity, location, and quality of vaso-occlusive pain in children with sickle cell disease.

Authors:  Eufemia Jacob; Christine Miaskowski; Marilyn Savedra; Judith E Beyer; Marsha Treadwell; Lori Styles
Journal:  Pain       Date:  2003-03       Impact factor: 6.961

4.  Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance.

Authors:  Samir K Ballas; Margaret Lusardi
Journal:  Am J Hematol       Date:  2005-05       Impact factor: 10.047

5.  Pain in sickle cell disease. Rates and risk factors.

Authors:  O S Platt; B D Thorington; D J Brambilla; P F Milner; W F Rosse; E Vichinsky; T R Kinney
Journal:  N Engl J Med       Date:  1991-07-04       Impact factor: 91.245

6.  Measuring pain quality: validity and reliability of children's and adolescents' pain language.

Authors:  Diana J Wilkie; William L Holzemer; Mary D Tesler; Judith Ann Ward; Steven M Paul; Marilyn C Savedra
Journal:  Pain       Date:  1990-05       Impact factor: 6.961

7.  A shift from demerol (meperidine) to dilaudid (hydromorphone) improves pain control and decreases admissions for patients in sickle cell crisis.

Authors:  Kathryn M Perlman; Suzanne Myers-Phariss; Jeremy C Rhodes
Journal:  J Emerg Nurs       Date:  2004-10       Impact factor: 1.836

Review 8.  Management of vasoocclusive pain events in sickle cell disease.

Authors:  Angela M Ellison; Kathy Shaw
Journal:  Pediatr Emerg Care       Date:  2007-11       Impact factor: 1.454

9.  Assessment of postoperation pain in children and adolescents using the adolescent pediatric pain tool.

Authors:  M C Savedra; W L Holzemer; M D Tesler; D J Wilkie
Journal:  Nurs Res       Date:  1993 Jan-Feb       Impact factor: 2.381

10.  Pain location: validity and reliability of body outline markings by hospitalized children and adolescents.

Authors:  M C Savedra; M D Tesler; W L Holzemer; D J Wilkie; J A Ward
Journal:  Res Nurs Health       Date:  1989-10       Impact factor: 2.228

  10 in total
  4 in total

Review 1.  Pain assessment using the adolescent pediatric pain tool: a systematic review.

Authors:  Ananda Maria Fernandes; Catarina De Campos; Luis Batalha; Ana Perdigão; Eufemia Jacob
Journal:  Pain Res Manag       Date:  2014-06-20       Impact factor: 3.037

2.  Remote monitoring of pain and symptoms using wireless technology in children and adolescents with sickle cell disease.

Authors:  Eufemia Jacob; Joana Duran; Jennifer Stinson; Mary Ann Lewis; Lonnie Zeltzer
Journal:  J Am Assoc Nurse Pract       Date:  2012-07-12       Impact factor: 1.165

3.  Current management of sickle cell anemia.

Authors:  Patrick T McGann; Alecia C Nero; Russell E Ware
Journal:  Cold Spring Harb Perspect Med       Date:  2013-08-01       Impact factor: 6.915

4.  Adolescent pediatric pain tool for multidimensional measurement of pain in children and adolescents.

Authors:  Eufemia Jacob; A Kyle Mack; Marilyn Savedra; Lois Van Cleve; Diana J Wilkie
Journal:  Pain Manag Nurs       Date:  2013-07-17       Impact factor: 1.929

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.